Search Results 2861-2870 of 16110 for chemoprevention
About this study. The purpose of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery ...
The use of telehealth during the COVID-19 pandemic rose dramatically across the nation, including at Mayo Clinic. Telehealth has provided safe, ...
It's well-known that exercise decreases the risk of developing cancer. Studies show there's a 25 percent reduction in the risk of breast cancer among the ...
About this study. This phase II trial studies how well hypofractionated radiation therapy works in treating participants with prostate cancer high-risk ...
The primary purposes of this study are to is to assess safety and tolerability of IV administration of TVH vaccine alone and in combination with HER2 antibodies ...
Title: ARAR2221, A Phase 2 Study Using Chemoimmunotherapy With Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
It's a time of year to raise awareness for breast cancer, especially since Michelle is not far removed from her initial diagnosis, treatment and recovery.
Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
Because Medicaid requires little to no insurance premium or out of pocket, traditional copay and grant assistance programs are limited. However, it is important ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.